搜尋
Belite Bio Inc
BLTE添加自選
173.790USD
-1.280-0.73%
收盤 09-11 16:00（美東）
6.98B總市值
虧損本益比TTM
股東統計
更新時間: 5月7日 週四
更新時間: 5月7日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Lin Bioscience International, Ltd.
42.78%
Darwin Global Management Ltd
7.58%
UBS Financial Services, Inc.
1.92%
RTW Investments L.P.
1.79%
Millennium Management LLC
1.40%
其他
44.54%
持股股東
持股股東
佔比
Lin Bioscience International, Ltd.
42.78%
Darwin Global Management Ltd
7.58%
UBS Financial Services, Inc.
1.92%
RTW Investments L.P.
1.79%
Millennium Management LLC
1.40%
其他
44.54%
股東類型
持股股東
佔比
Corporation
42.78%
Hedge Fund
10.97%
Investment Advisor
3.78%
Investment Advisor/Hedge Fund
3.07%
Individual Investor
1.63%
Venture Capital
1.08%
Private Equity
1.04%
Research Firm
0.24%
其他
35.42%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
106
8.07M
20.19%
+4.96M
2025Q4
63
2.48M
1.49%
+1.93K
2025Q3
67
2.47M
1.71%
+2.23M
2025Q2
53
243.27K
1.55%
+4.98K
2025Q1
54
243.12K
1.48%
-238.72K
2024Q4
48
354.52K
0.86%
+204.54K
2024Q3
41
149.94K
1.25%
-107.11K
2024Q2
39
255.75K
0.89%
+121.28K
2024Q1
35
133.24K
1.23%
-231.82K
2023Q4
33
240.66K
0.76%
+66.56K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Lin Bioscience International, Ltd.
17.10M
43.46%
--
--
Mar 14, 2025
Darwin Global Management Ltd
3.03M
7.7%
+3.03M
--
Dec 31, 2025
UBS Financial Services, Inc.
94.30K
0.24%
+90.20K
+2202.81%
Dec 31, 2025
RTW Investments L.P.
715.33K
1.82%
+402.83K
+128.91%
Dec 31, 2025
Millennium Management LLC
558.88K
1.42%
+538.14K
+2594.58%
Dec 31, 2025
RA Capital Management, LP
432.48K
1.1%
-442.52K
-50.57%
Dec 31, 2025
Perceptive Advisors LLC
414.24K
1.05%
+364.45K
+732.01%
Dec 31, 2025
Eventide Asset Management, LLC
383.09K
0.97%
+187.78K
+96.14%
Dec 31, 2025
Lin (Yu-Hsin)
373.48K
0.95%
-21.29K
-5.39%
Mar 14, 2025
Chuang (Hao-Yuan)
82.26K
0.21%
-229.95K
-73.65%
Mar 14, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Virtus LifeSci Biotech Clinical Trials ETF
1.15%
SPDR S&P China ETF
0.04%
ActivePassive International Equity ETF
0.02%
SPDR Portfolio Emerging Markets ETF
0.01%
Fidelity Nasdaq Composite Index ETF
0.01%
SPDR S&P Emerging Markets Small Cap ETF
0%
Virtus LifeSci Biotech Clinical Trials ETF
佔比1.15%
SPDR S&P China ETF
佔比0.04%
ActivePassive International Equity ETF
佔比0.02%
SPDR Portfolio Emerging Markets ETF
佔比0.01%
Fidelity Nasdaq Composite Index ETF
佔比0.01%
SPDR S&P Emerging Markets Small Cap ETF
佔比0%